Review
Version 1
Preserved in Portico This version is not peer-reviewed
New Onset Diabetes Mellitus After Transplantation
Version 1
: Received: 5 February 2024 / Approved: 6 February 2024 / Online: 6 February 2024 (09:17:33 CET)
A peer-reviewed article of this Preprint also exists.
Alajous, S.; Budhiraja, P. New-Onset Diabetes Mellitus after Kidney Transplantation. J. Clin. Med. 2024, 13, 1928. Alajous, S.; Budhiraja, P. New-Onset Diabetes Mellitus after Kidney Transplantation. J. Clin. Med. 2024, 13, 1928.
Abstract
New onset diabetes mellitus after transplantation (NODAT) is a common complication following solid organ transplantation, with varying incidence rates due to discrepancies in defining NODAT and follow-up duration, alongside modifiable and non-modifiable risk factors. NODAT adversely affects patient survival and graft longevity, warranting early detection, especially in countries experiencing a rise in kidney transplant cases, emphasizing the need for understanding diagnostic criteria, risk factors, pathogenic mechanisms, and post-transplant outcomes.
Keywords
NODAT; transplant; Kidney; HbA1c; GLP1 AR; Metformin
Subject
Biology and Life Sciences, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
